8436.TWO · TCI
Taiwan · RS rating 22 · As of 2026-10-08
| Price | 103.00 TWD |
|---|---|
| 1-day change | +0.5% |
| RS rating (overall / 1M / 3M / 12M) | 22 / 11 / 40 / 42 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 32 / 14 / 32 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | +16.2% |
| Sales growth Q/Q | +4.4% |
| Distance from 52-week high | +35.2% |
| Market cap (USD) | $358.9M |